Five factors that position Holista Colltech for unabated growth in 2022 and beyond

Be the First to Comment Read

Five factors that position Holista Colltech for unabated growth in 2022 and beyond

Holista Colltech, ASX, a health & wellness company
Image source: HCT Presentation, dated 12 November 2021



  • Holista Colltech is a research-driven biotech company committed to delivering high-quality natural ingredients and wellness products.
  • The Company offers comprehensive COVID-19 test kits and disinfectants.
  • Holista has several strategic agreements that widen its footprints in the health & wellness space.
  • The Company is at a vantage point when it comes to cashing in on the exciting market opportunities, owing to its global reach, diversified product portfolio and defensive revenue streams.

Perth-headquartered research-driven biotech company Holista Colltech Limited (ASX:HCT) is committed to delivering high-quality natural ingredients and wellness products. The Company also leads in research on herbs and food ingredients.

Holista has continued to undertake a slew of developments across its all four divisions to leverage growth prospects induced from the pandemic concerns. These include the launch of comprehensive COVID-19 test kits and disinfectants in addition to inking several strategic agreements that widen the Company’s footprint in the health & wellness space.

GOOD WATCH: How is Holista Colltech tapping market opportunities steered by COVID-19 outbreak?

Holista’s four divisions

Source: Copyright © 2022 Kalkine Media®

Thus, it would be safe to say that Holista is at a vantage point when it comes to cashing in on the exciting market opportunities. With this backdrop, let us explore the reasons in detail that position the Company well for growth.

ALSO READ: Big upside in 2022 for Holista Colltech’s ovine collagen in buoyant skincare market

1. Multiple growth avenues with defensive revenue streams

Holista enjoys multiple growth avenues with its diverse divisions exposed to tap several mushrooming prospects.

From conscious nutrition choices to growing concerns for infections, several trends continue to boost business for Holista’s different divisions.

The Company’s sales and earnings have remained relatively stable despite the pandemic downturns. The fact that Holista operates in the health & wellness industry provides it further stability concerning the demand for its products. 

ALSO READ: How Holista Colltech’s superior food alternatives drive healthy living and profits

2. Global reach with proven products sold around the world

Australia-based Holista has an extensive presence in Malaysia. The Company’s partnership with Berjaya’s Country Farms has opened opportunities into several leading franchises in Malaysia such as Starbucks, Kenny Rogers, and 7-Eleven.

In addition to Malaysia, the recent strategic deals have expanded the reach of Holista’s proven products in other parts of the world.

Some of these deals and developments include:

  • Deal signed with Costanzo’s to launch the world’s lowest GI clean label white bread in the US
  • Exclusive distribution agreement for ovine collagen into China
  • Approval of Natshield™ trademark in China

3. Large addressable and growing markets in health/wellness

The concept of health & wellness has broadened significantly over the past few years, with consumers now viewing wellness to not just encompass fitness and nutrition but also overall physical and mental health and appearance.

Moreover, there has been a substantive rise in consumer interest and purchasing power, which together presents opportunities for companies such as Holista, spending significantly on personal wellness.

ALSO READ: Omicron COVID mutation pushes Holista Colltech’s Infection Control division further along high-growth path

4. Positive outlook with further growth momentum expected

Global trends support further growth over medium- to longer-term for all Holista’s divisions. Trading conditions in 2021 showed marked improvement over the previous year.

Key market factors are fuelling growth momentum of the Company's varying divisions:

  • Healthy Food- Growing consumer focus on healthier foods to drive growth
  • Infection Control- New product launches and potential expansion into China to fuel the next phase of growth
  • Dietary Supplements- New products contributing to growth
  • Ovine Collagen- Major plant expansion when potentially a transformative deal with China becomes binding

ALSO READ: How Holista Colltech (ASX:HCT) is fast-tracking its growth into FY22

5. Improved results expected and ready for 2022 prospects

Holista is seeing several significant growth opportunities that can lead to a significant step-change in the Company’s earnings over short- to medium-term. Meanwhile, profit margins for the Company are expected to improve on 2021 due to cost optimisation and organic growth.

HCT shares traded at AU$0.041 on 21 January 2022.   


Speak your Mind

Featured Articles

kalkine logo


Top Penny Picks under 20 Cents to Fit Your Pocket! Get Exclusive Report on Penny Stocks For FREE Now.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK